大流行后的远程医疗：逆向医疗定律是否适用？（评论）。
Telehealth after the pandemic: Will the inverse care law apply? (Commentary).
机构信息
Division of Child Health, Obstetrics & Gynaecology, University of Nottingham, Queens Medical Centre, UK.
Division of Child Health, Obstetrics & Gynaecology, University of Nottingham, Queens Medical Centre, UK.
出版信息
J Cyst Fibros. 2021 Dec;20 Suppl 3:47-48. doi: 10.1016/j.jcf.2021.08.023. Epub 2021 Sep 11.
Abstract
The COVID-19 pandemic has accelerated the use of telehealth within the cystic fibrosis (CF) community to deliver CF care. The article by Solomon and colleagues exploring the patient and family experiences of telehealth care delivery, as part of the CF chronic care model in the US, is therefore timely. In this commentary, we discuss how the US experience of telehealth care compares with reports from CF centres in other parts of the world. We highlight the potential challenges, including whether the inverse care law will apply in this new era of CF telehealth.
摘要
COVID-19 大流行加速了囊性纤维化 (CF) 社区内远程医疗的使用，以提供 CF 护理。因此，Solomon 及其同事的文章探讨了美国 CF 慢性病管理模式中远程医疗护理的患者和家庭体验，非常及时。在这篇评论中，我们讨论了美国远程医疗护理的经验如何与世界其他 CF 中心的报告进行比较。我们强调了潜在的挑战，包括在这个 CF 远程医疗新时代是否会适用逆向医疗保健法。
相似文献
1
Telehealth after the pandemic: Will the inverse care law apply? (Commentary).
J Cyst Fibros. 2021 Dec;20 Suppl 3:47-48. doi: 10.1016/j.jcf.2021.08.023. Epub 2021 Sep 11.
2
Design and methods for understanding the state of cystic fibrosis care amid the COVID-19 pandemic.
J Cyst Fibros. 2021 Dec;20 Suppl 3:3-8. doi: 10.1016/j.jcf.2021.08.028.
3
Evaluating barriers to and promotors of telehealth during the COVID-19 pandemic at U.S. cystic fibrosis programs (Commentary).
J Cyst Fibros. 2021 Dec;20 Suppl 3:14-15. doi: 10.1016/j.jcf.2021.08.026. Epub 2021 Sep 2.
4
Telehealth and virtual health monitoring in cystic fibrosis.
Curr Opin Pulm Med. 2021 Nov 1;27(6):544-553. doi: 10.1097/MCP.0000000000000821.
5
Patient and family experience of telehealth care delivery as part of the CF chronic care model early in the COVID-19 pandemic.
J Cyst Fibros. 2021 Dec;20 Suppl 3:41-46. doi: 10.1016/j.jcf.2021.09.005.
6
Evaluating barriers to and promoters of telehealth during the COVID-19 pandemic at U.S. cystic fibrosis programs.
J Cyst Fibros. 2021 Dec;20 Suppl 3:9-13. doi: 10.1016/j.jcf.2021.08.034.
7
Factors associated with receiving CF care and use of telehealth in 2020 among persons with Cystic Fibrosis in the United States.
J Cyst Fibros. 2023 May;22(3):456-463. doi: 10.1016/j.jcf.2022.12.004. Epub 2022 Dec 14.
8
Favorable Clinician Acceptability of Telehealth as Part of the Cystic Fibrosis Care Model during the COVID-19 Pandemic.
Ann Am Thorac Soc. 2021 Sep;18(9):1588-1592. doi: 10.1513/AnnalsATS.202012-1484RL.
9
Barriers and facilitators to implementing telehealth services during the COVID-19 pandemic: A qualitative analysis of interviews with cystic fibrosis care team members.
J Cyst Fibros. 2021 Dec;20 Suppl 3:23-28. doi: 10.1016/j.jcf.2021.09.004.
10
Home spirometry utilisation in telemedicine clinic for cystic fibrosis care during COVID-19 pandemic: a quality improvement process.
BMJ Open Qual. 2021 Aug;10(3). doi: 10.1136/bmjoq-2021-001529.
引用本文的文献
1
CF Tummy Tracker: A Cystic Fibrosis-Specific Patient-Reported Outcome Measure for Daily Gastrointestinal Symptom Burden.
Mayo Clin Proc Digit Health. 2025 Mar 3;3(2):100203. doi: 10.1016/j.mcpdig.2025.100203. eCollection 2025 Jun.
2
To What Extent Can Digital Health Technologies Comply With the Principles of Responsible Innovation? Practice-and Policy-Oriented Research Insights Regarding an Organisational and Systemic Issue.
Int J Health Policy Manag. 2024;13:8061. doi: 10.34172/ijhpm.8061. Epub 2024 Oct 21.
3
A grumbling concern: A survey of gastrointestinal symptoms in cystic fibrosis in the modulator era.
NIHR Open Res. 2024 Feb 5;3:18. doi: 10.3310/nihropenres.13384.1. eCollection 2023.
4
Virtual Care and the Inverse Care Law: Implications for Policy, Practice, Research, Public and Patients.
Int J Environ Res Public Health. 2022 Aug 25;19(17):10591. doi: 10.3390/ijerph191710591.
5
A year in review: Real world evidence, functional monitoring and emerging therapeutics in 2021.
J Cyst Fibros. 2022 Mar;21(2):191-196. doi: 10.1016/j.jcf.2022.02.014. Epub 2022 Mar 7.
6
The impact of COVID-19 upon the delivery of exercise services within cystic fibrosis clinics in the United Kingdom.
Clin Respir J. 2022 Apr;16(4):335-340. doi: 10.1111/crj.13484. Epub 2022 Mar 1.
本文引用的文献
1
Cystic Fibrosis Respiratory Microbiology Monitoring during a Global Pandemic: Lessons Learned from a Shift to Telehealth.
Ann Am Thorac Soc. 2022 Mar;19(3):498-500. doi: 10.1513/AnnalsATS.202101-087RL.
2
Telemedicine and cystic fibrosis: Do we still need face-to-face clinics?
Paediatr Respir Rev. 2022 Jun;42:23-28. doi: 10.1016/j.prrv.2021.05.002. Epub 2021 May 19.
3
What effective ways of motivation, support and technologies help people with cystic fibrosis improve and sustain adherence to treatment?
BMJ Open Respir Res. 2020 Aug;7(1). doi: 10.1136/bmjresp-2020-000601.
4
Discrepancy between Lung Function Measurements at Home and in the Hospital in Children with Asthma and CF.
J Clin Med. 2020 May 26;9(6):1617. doi: 10.3390/jcm9061617.
5
Characterising burden of treatment in cystic fibrosis to identify priority areas for clinical trials.
J Cyst Fibros. 2020 May;19(3):499-502. doi: 10.1016/j.jcf.2019.10.025. Epub 2019 Nov 15.
6
Using digital technology for home monitoring, adherence and self-management in cystic fibrosis: a state-of-the-art review.
Thorax. 2020 Jan;75(1):72-77. doi: 10.1136/thoraxjnl-2019-213233. Epub 2019 Oct 8.
7
Supporting medication adherence for adults with cystic fibrosis: a randomised feasibility study.
BMC Pulm Med. 2019 Apr 11;19(1):77. doi: 10.1186/s12890-019-0834-6.
8
ECFS best practice guidelines: the 2018 revision.
J Cyst Fibros. 2018 Mar;17(2):153-178. doi: 10.1016/j.jcf.2018.02.006. Epub 2018 Mar 3.
9
The inverse care law.
Lancet. 1971 Feb 27;1(7696):405-12. doi: 10.1016/s0140-6736(71)92410-x.
Zotero 插件